{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T03:53:36Z","timestamp":1767930816339,"version":"3.49.0"},"reference-count":13,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hamostaseologie"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We report the case of a 59-year-old multiple myeloma patient in whom an anti-human thrombin IgA antibody led to prolonged in vitro coagulation times, suggesting inhibitors to all intrinsic coagulation factors in the absence of spontaneous bleeding.<\/jats:p>\n                  <jats:p>Routine and extensive special coagulation tests, in vivo bleeding time, and specific antibody testing were performed.<\/jats:p>\n                  <jats:p>Although the patient did not suffer from spontaneous bleeding and had a normal in vivo bleeding time, the anti-human thrombin IgA autoantibody affected all coagulation assays involving human thrombin in vitro, mimicking inhibitors to intrinsic coagulation factors. As the IgA paraprotein and the IgA antibody virtually disappeared after autologous stem cell transplantation, the coagulation tests also largely normalized.<\/jats:p>\n                  <jats:p>Antibodies to human thrombin may interfere with all coagulation assays involving thrombin, imitating a severe coagulopathy. However, in vivo they do not necessarily lead to strongly increased bleeding tendency. Complex and ambiguous coagulation abnormalities should be evaluated and treated in an interdisciplinary setting, including a highly specialized coagulation laboratory, from the beginning.<\/jats:p>","DOI":"10.1055\/a-2211-6841","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T19:20:39Z","timestamp":1709320839000},"page":"505-510","source":"Crossref","is-referenced-by-count":1,"title":["Anti-Thrombin IgA in a Patient with Multiple Myeloma Leading to In Vitro Interference in Multiple Coagulation Tests and Confounding Diagnosis"],"prefix":"10.1055","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4901-8861","authenticated-orcid":false,"given":"Christian","family":"Irsara","sequence":"additional","affiliation":[{"name":"Central Institute of Medical and Chemical Laboratory Diagnostics (ZIMCL), University Hospital of Innsbruck, Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Griesmacher","sequence":"additional","affiliation":[{"name":"Central Institute of Medical and Chemical Laboratory Diagnostics (ZIMCL), University Hospital of Innsbruck, Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorin","family":"Loacker","sequence":"additional","affiliation":[{"name":"Central Institute of Medical and Chemical Laboratory Diagnostics (ZIMCL), University Hospital of Innsbruck, Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Feistritzer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosima Anna","family":"\u00dcberbacher","sequence":"additional","affiliation":[{"name":"Hemato-Oncological Day Hospital, Franz Tappeiner Hospital, Merano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Amiral","sequence":"additional","affiliation":[{"name":"Scientific-Hemostasis Consulting, Franconville, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"issue":"05","key":"ref1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: a review","volume":"327","author":"A J Cowan","year":"2022","journal-title":"JAMA"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"S V Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.5858\/arpa.2020-0441-OA","article-title":"Identification of paraproteins via serum immunofixation or serum immunosubtraction and immunoturbidimetric quantitation of serum immunoglobulins in the laboratory testing for monoclonal gammopathies","volume":"145","author":"I Mrosewski","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbacli.2016.05.004","article-title":"Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"6","author":"A Shimanovsky","year":"2016","journal-title":"BBA Clin"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-0038-1627480","article-title":"International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of direct oral anticoagulants","volume":"118","author":"R C Gosselin","year":"2018","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/rth2.12252","article-title":"Prolonged APTT of unknown etiology: a systematic evaluation of causes and laboratory resource use in an outpatient hemostasis academic unit","volume":"3","author":"A CN Barbosa","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/ejh.13193","article-title":"Inhibitors in haemophilia A and B: management of bleeds, inhibitor eradication and strategies for difficult-to-treat patients","volume":"102","author":"R Ljung","year":"2019","journal-title":"Eur J Haematol"},{"issue":"05","key":"ref8","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/blood-2006-06-029850","article-title":"Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation","volume":"109","author":"P W Collins","year":"2007","journal-title":"Blood"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1538-7836.2012.04654.x","article-title":"Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)","volume":"10","author":"P Knoebl","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0038-1650169","article-title":"A survey of 215 non-hemophilic patients with inhibitors to Factor VIII","volume":"45","author":"D Green","year":"1981","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2141.2006.06087.x","article-title":"The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation","volume":"133","author":"C R Hay","year":"2006","journal-title":"Br J Haematol"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1538-7836.2012.04705.x","article-title":"Validation of Nijmegen-Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance","volume":"10","author":"C H Miller","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/jth.13171","article-title":"Discovery and characterization of an antibody directed against exosite I of thrombin","volume":"14","author":"T P Baglin","year":"2016","journal-title":"J Thromb Haemost"}],"container-title":["H\u00e4mostaseologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2211-6841.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:31:32Z","timestamp":1767915092000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2211-6841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":13,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2026,1,8]]},"published-print":{"date-parts":[[2025,12]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2211-6841","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0720-9355","2567-5761"],"issn-type":[{"value":"0720-9355","type":"print"},{"value":"2567-5761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]}}}